The treatment for Simon Goodrich’s disease has been costing $12,000 a month, but there has been a huge development.

Five people were inside a home on Milwaukee's north side when a fire broke out on Wednesday, Jan 15, including a mother who says her 56-year-old neighbor started the blaze. Mi ...

Cheryl Hines, the spouse to Robert F. Kennedy Jr., Donald Trump's pick to be HHS secretary, had used her husband's image and ...

Ahead of a Supreme Court ruling, they are mocking U.S. national security concerns about the Chinese-owned app.

REPORT It’s Thursday. For all my tennis friends out there, American tennis player Madison Keys pulled off an incredible ...

Aspargo Labs, Inc., ("Aspargo Labs” or the "Company”), a specialty pharmacy and MedTech company focused on converting the ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...

Merck & Co. Inc. closed 27.25% short of its 52-week high of $134.63, which the company reached on June 25th.

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

Merck (MRK) and Esai (ESALF) (ESAIY) announce a mixed outcome in their Phase 3 LEAP-015 trial for Keytruda/ Lenvima regimen ...

In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...